Samantha Hol

910 total citations
16 papers, 736 citations indexed

About

Samantha Hol is a scholar working on Oncology, Immunology and Pharmacology. According to data from OpenAlex, Samantha Hol has authored 16 papers receiving a total of 736 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 11 papers in Immunology and 3 papers in Pharmacology. Recurrent topics in Samantha Hol's work include CAR-T cell therapy research (10 papers), T-cell and B-cell Immunology (7 papers) and Immune Cell Function and Interaction (7 papers). Samantha Hol is often cited by papers focused on CAR-T cell therapy research (10 papers), T-cell and B-cell Immunology (7 papers) and Immune Cell Function and Interaction (7 papers). Samantha Hol collaborates with scholars based in Netherlands, Germany and United States. Samantha Hol's co-authors include Anton Hagenbeek, Saskia B. Ebeling, Tom van Meerten, Rozemarijn S. van Rijn, Jürgen Kuball, Suzanne van Dorp, Sabine Heijhuurs, Zsolt Sebestyén, Wouter Scheper and Ruud Delwel and has published in prestigious journals such as Blood, Journal of Virology and Clinical Cancer Research.

In The Last Decade

Samantha Hol

16 papers receiving 723 citations

Peers

Samantha Hol
Jaume Pons United States
Matthew Schrage United States
Patricia A. Forsythe United States
Annette E. Maluish United States
Casimir de Rham Switzerland
Hongkang Xi United States
Jaume Pons United States
Samantha Hol
Citations per year, relative to Samantha Hol Samantha Hol (= 1×) peers Jaume Pons

Countries citing papers authored by Samantha Hol

Since Specialization
Citations

This map shows the geographic impact of Samantha Hol's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Samantha Hol with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Samantha Hol more than expected).

Fields of papers citing papers by Samantha Hol

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Samantha Hol. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Samantha Hol. The network helps show where Samantha Hol may publish in the future.

Co-authorship network of co-authors of Samantha Hol

This figure shows the co-authorship network connecting the top 25 collaborators of Samantha Hol. A scholar is included among the top collaborators of Samantha Hol based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Samantha Hol. Samantha Hol is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Straetemans, Trudy, Sabine Heijhuurs, Samantha Hol, et al.. (2015). Untouched GMP-Ready Purified Engineered Immune Cells to Treat Cancer. Clinical Cancer Research. 21(17). 3957–3968. 22 indexed citations
2.
Scheper, Wouter, Suzanne van Dorp, Sabina Kersting, et al.. (2013). γδT cells elicited by CMV reactivation after allo-SCT cross-recognize CMV and leukemia. Leukemia. 27(6). 1328–1338. 149 indexed citations
3.
Dorp, Suzanne van, Samantha Hol, Esther Drent, et al.. (2012). γ9 and δ2CDR3 domains regulate functional avidity of T cells harboring γ9δ2TCRs. Blood. 120(26). 5153–5162. 66 indexed citations
4.
Kuball, Jürgen, Karin Boer, Eva Wagner, et al.. (2010). Pitfalls of vaccinations with WT1-, Proteinase3- and MUC1-derived peptides in combination with MontanideISA51 and CpG7909. Cancer Immunology Immunotherapy. 60(2). 161–171. 66 indexed citations
6.
Meerten, Tom van, Rozemarijn S. van Rijn, Samantha Hol, Anton Hagenbeek, & Saskia B. Ebeling. (2006). Complement-Induced Cell Death by Rituximab Depends on CD20 Expression Level and Acts Complementary to Antibody-Dependent Cellular Cytotoxicity. Clinical Cancer Research. 12(13). 4027–4035. 181 indexed citations
8.
Ivanov, Roman, et al.. (2005). UTY‐specific TCR‐transfer generates potential graft‐versus‐leukaemia effector T cells. British Journal of Haematology. 129(3). 392–402. 13 indexed citations
10.
Ivanov, Roman, et al.. (2005). T cell receptor-transgenic primary T cells as a tool for discovery of leukaemia-associated antigens. Clinical & Experimental Immunology. 143(1). 78–84. 5 indexed citations
11.
Ivanov, Roman, et al.. (2005). Identification of a 40S Ribosomal Protein S4–Derived H-Y Epitope Able to Elicit a Lymphoblast-Specific Cytotoxic T Lymphocyte Response. Clinical Cancer Research. 11(5). 1694–1703. 33 indexed citations
12.
Ebeling, Saskia B., H P E Borst, Elles Simonetti, et al.. (2003). Development and application of quantitative real time PCR and RT-PCR assays that discriminate between the full-length and truncated herpes simplex virus thymidine kinase gene. Journal of Virological Methods. 109(2). 177–186. 5 indexed citations
13.
Ebeling, Saskia B., Roman Ivanov, Samantha Hol, et al.. (2003). HLA‐DRB1*16‐restricted recognition of myeloid cells, including CD34+ CML progenitor cells. British Journal of Haematology. 121(5). 721–729. 4 indexed citations
14.
Valk, Peter J.M., Samantha Hol, Rob E. Ploemacher, et al.. (1997). Anandamide, a Natural Ligand for the Peripheral Cannabinoid Receptor Is a Novel Synergistic Growth Factor for Hematopoietic Cells. Blood. 90(4). 1448–1457. 89 indexed citations
15.
Valk, Peter J.M., Samantha Hol, J N Ihle, et al.. (1997). The genes encoding the peripheral cannabinoid receptor and alpha-L-fucosidase are located near a newly identified common virus integration site, Evi11. Journal of Virology. 71(9). 6796–6804. 42 indexed citations
16.
Valk, Peter J.M., Samantha Hol, Rob E. Ploemacher, et al.. (1997). Anandamide, a Natural Ligand for the Peripheral Cannabinoid Receptor Is a Novel Synergistic Growth Factor for Hematopoietic Cells. Blood. 90(4). 1448–1457. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026